These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34974339)

  • 1. Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.
    Spiliopoulou A; Kolonitsiou F; Vrioni G; Tsoupra S; Lekkou A; Paliogianni F
    J Mycol Med; 2022 May; 32(2):101236. PubMed ID: 34974339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study.
    Liao X; Qiu H; Li R; Guo F; Liu W; Kang M; Kang Y;
    J Crit Care; 2015 Aug; 30(4):862.e1-5. PubMed ID: 26002430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay.
    Maseda E; Rodríguez AH; Aguilar G; Pemán J; Zaragoza R; Ferrer R; Llinares P; Grau S;
    Rev Iberoam Micol; 2016; 33(4):196-205. PubMed ID: 27422492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
    Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
    Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapies in murine infections by Candida kefyr.
    Sanchis M; Martin-Vicente A; Capilla J; Guarro J
    Mycoses; 2016 Apr; 59(4):253-258. PubMed ID: 26857550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L; Asadzadeh M
    PLoS One; 2020; 15(10):e0240426. PubMed ID: 33108361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emerging pathogen: Candida kefyr (Kluvyeromyces marxianus)].
    Çuhadar T; Kalkancı A
    Mikrobiyol Bul; 2017 Oct; 51(4):387-395. PubMed ID: 29153069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility of fungi isolated from ICU patients.
    Modrzewska BD; Kurnatowska, AJ; Khalid K
    Ann Parasitol; 2017; 63(3):189-198. PubMed ID: 29274212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive candidiasis in Africa, what is the current picture?
    Okoye CA; Nweze E; Ibe C
    Pathog Dis; 2022 Jun; 80(1):. PubMed ID: 35451463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida urinary tract infections--treatment.
    Fisher JF; Sobel JD; Kauffman CA; Newman CA
    Clin Infect Dis; 2011 May; 52 Suppl 6():S457-66. PubMed ID: 21498839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
    Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
    BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida kefyr, an uncommon but emerging fungal pathogen: report of two cases.
    Corpus K; Hegeman-Dingle R; Bajjoka I
    Pharmacotherapy; 2004 Aug; 24(8):1084-8. PubMed ID: 15338856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
    Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units.
    Montravers P; Mira JP; Gangneux JP; Leroy O; Lortholary O;
    Clin Microbiol Infect; 2011 Jul; 17(7):1061-7. PubMed ID: 20825438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidiasis caused by Candida kefyr in a neonate: case report.
    Weichert S; Reinshagen K; Zahn K; Geginat G; Dietz A; Kilian AK; Schroten H; Tenenbaum T
    BMC Infect Dis; 2012 Mar; 12():61. PubMed ID: 22424058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
    Golan Y; Wolf MP; Pauker SG; Wong JB; Hadley S
    Ann Intern Med; 2005 Dec; 143(12):857-69. PubMed ID: 16365467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
    Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
    Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.